Evidence map›Paper›PMID 41473239›Full record

ArticleFrontiers in endocrinology2025

Comparison of different insulin resistance surrogates in predicting hyperuricemia in non-diabetic Yi residents in Yunnan Province.

Mengyao Dao, Xianyu He, Yanmei Ji, Ni Guo, Wenjun Li, Qing Xiong, Ni Meng, Dan Zhou, Ting Pi, Xiaofeng Zong and 4 more

Abstract readComparative Study
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mengyao Dao *Clinical Medical Research Center for Cardiovascular Disease of Yunnan Province, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
Xianyu He *Clinical Medical Research Center for Cardiovascular Disease of Yunnan Province, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
Yanmei JiDepartment of Cardiovascular Surgery, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
Ni GuoClinical Medical Research Center for Cardiovascular Disease of Yunnan Province, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
Wenjun LiDepartment of Cardiovascular Surgery, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
Qing XiongDepartment of Endocrinology, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
Ni MengClinical Medical Research Center for Cardiovascular Disease of Yunnan Province, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
Dan ZhouClinical Medical Research Center for Cardiovascular Disease of Yunnan Province, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
Ting PiDepartment of Pharmacy, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
Xiaofeng ZongClinical Medical Research Center for Cardiovascular Disease of Yunnan Province, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
Meirong YangClinical Medical Research Center for Cardiovascular Disease of Yunnan Province, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
Xinyi LiuClinical Medical Research Center for Cardiovascular Disease of Yunnan Province, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
Zhongjuan WangDepartment of Pharmacy, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
Xingfang JinClinical Medical Research Center for Cardiovascular Disease of Yunnan Province, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Hyperuricemia (HUA) is one of the most common metabolic diseases in China, with an incidence of up to 36% across different ethnic groups. Insulin resistance (IR) plays a specific role in the occurrence and development of HUA, but relevant studies on the non-diabetic Yi residents in Yunnan are limited. Our study aimed to explore the triglyceride-glucose index (TyG), triglyceride-glucose and body mass index (TyG-BMI), triglyceride/high-density lipoprotein cholesterol ratio (TG/HDL-C), and the metabolic score for insulin resistance (METS-IR) among non-diabetic Yi residents in Yunnan Province, and identify the IR surrogates with high predictive ability for HUA. Materials and methods: From November 2018 to September 2023, our group finally included 765 Yi residents aged ≥18 years on the basis of the inclusion criteria. The participants were divided into the non-HUA and HUA groups. Logistic regression analysis was used to describe the association between four IR surrogates and HUA and calculate odds ratios (ORs), while the receiver operating characteristic curve was utilized to assess the prediction ability of these four IR surrogates. Results: Among the 765 non-diabetic Yi residents in Yunnan, 666 were in the non-HUA group, and 99 were in the HUA group. A history of smoking, alcohol consumption, hypertension, and hyperlipidemia, body mass index (BMI) ≥ 24 kg/m Conclusion: This study found that in non-diabetic Yi residents in six areas of Yunnan Province, the TyG, TyG-BMI, TG/HDL-C, and METS-IR were positively correlated with HUA. These four IR surrogates were good at predicting HUA.

Indexed as

BiomarkersHyperuricemiaInsulin ResistanceAdultAgedBlood GlucoseBody Mass IndexChinaCholesterol, HDLFemaleHumansMaleMiddle AgedPrognosisRisk FactorsTriglyceridesBiomarkersBlood GlucoseCholesterol, HDLTriglycerideshyperuricemiainsulin resistance surrogatenon-diabetic populationpredictive abilityYi resident in Yunnan

Identifiers

PMID41473239
PMCPMC12745241

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.